DTAB CLEARS EXPORT OF NEW MOLECULES, STRINGS ATTACHED

Article Abstract:

The Drug Technical Advisory Board (DTAB) has permitted export of molecules that are not permitted to be sold in the domestic markets. However the DTAB has laid down 17 conditions to be fulfilled before export permission is given. Some of the conditions include a method for checking the possible misuse of export licenses, where products designated for the export markets are sold in the Indian market. The guidelines specified by the DTAB is similar to the guidelines of the Food and Drug Administration of USA. (uh)(vr)

International economic relations, Drugs

---

RANBAXY TO GO FOR MOLECULE LICENSING AFTER PHASE I TRIALS

Article Abstract:

Ranbaxy Laboratories plans to go for a licensing deal for RBx 2258, its original research molecule for the treatment of benign prostatic hypertrophy only after completion of phase I clinical trials in India. The company has applied to the Drug Controller of India for permission to carry out the clinical trials, which may take up to a year. (khr)

Comment:

Ranbaxy Laboratories plans to go for a licensing deal for RBx 2258, its original research molecule for the treatment of benign prostatic hypertrophy only after completion of phase I clinical trials in India.

Product development, Ranbaxy Laboratories Ltd.

---

Similar abstracts:

• Abstracts: FIs ASK CASH-STRAPPED PROMOTERS TO PLEDGE HOLDINGS. BANKAM TO TRIM WHOLESALE LENDING BUSINESS IN INDIA
• Abstracts: FOREX RESERVES GO UP BY $530 MILLION L&T STRIKES THE FIRST EURO FOREX DEAL IN INDIA. FOREX KITTY POORER BY $3.5 BILLION ON GOLD IMPORTS
• Abstracts: SAIL CROWNED NAVRATNA WITH 3 NEW DIRECTORS SAIL TO CLOSE DOWN UNVIABLE NON-CORE UNITS SAIL SHOWS 7 GOOD REASONS TO OPT FOR VRS
• Abstracts: P&G (I) OFFERS VRS TO 1,100 EMPLOYEES GODREJ LIKELY TO INCREASE SOAP PRICES
• Abstracts: BUCKEYE TO SET UP EXECUTIVE PARK PFs DEVELOP APPETITE FOR PRIVATE SECTOR DEBT, BUY BIG IN 3 ISSUES

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.